1. Anabolic steroid use rife in the US

   Clinical study 08 February 2013 Pages: 2 - 2

2. Artificial sweetener induces exanthema.

   Case report 08 February 2013 Pages: 2 - 2

3. Nifedipine danger in primary pulmonary hypertension

   Correspondence 08 February 2013 Pages: 2 - 2

4. Triazolam's narrow safety margin is unacceptable

   Correspondence 08 February 2013 Pages: 2 - 2

5. Chloroquine and myasthenia data scarce

   Correspondence 08 February 2013 Pages: 3 - 3

6. Does lithium impair memory?

   Review 08 February 2013 Pages: 3 - 3

7. IV ciprofloxacin was found to be compatible with most other drugs

   In vitro 08 February 2013 Pages: 3 - 3

8. Norvasc® scripts mistaken for Navane®

   News item 08 February 2013 Pages: 3 - 3

9. Amidotriozate

   Case reports 08 February 2013 Pages: 4 - 4

10. Antineoplastics

    Case report 08 February 2013 Pages: 4 - 4

11. Antineoplastics

    Case reports 08 February 2013 Pages: 4 - 4

12. Concerns over saccharin's reappearance

    Correspondence 08 February 2013 Pages: 4 - 4

13. Ibogaine neurotoxic in rodents.

    News item 08 February 2013 Pages: 4 - 4

14. The carcinogenciciy of lidocaine in rodents cannot be extrapolated to humans,

    News item 08 February 2013 Pages: 4 - 4

15. Benzodiazepines

    Clinical study 08 February 2013 Pages: 5 - 5

16. Carbamazepine

    Case report 08 February 2013 Pages: 5 - 5

17. Ceftibuten

    Incidence study 08 February 2013 Pages: 5 - 5

18. Ceftriaxone

    Case report 08 February 2013 Pages: 5 - 5

19. Chloral hydrate

    Case reports 08 February 2013 Pages: 5 - 5

20. Clofazimine

    Case report 08 February 2013 Pages: 6 - 6

21. Clonidine

    Case report 08 February 2013 Pages: 6 - 6

22. Clozapine

    Incidence study 08 February 2013 Pages: 6 - 6

23. Cyclosporin

    Incidence study 08 February 2013 Pages: 6 - 6

24. Cytarabine

    Case reports 08 February 2013 Pages: 6 - 6

25. Dextran 70

    Case report 08 February 2013 Pages: 6 - 6

26. Docetaxel

    Clinical study 08 February 2013 Pages: 7 - 7

27. Esmolol/neostigmine

    Case report 08 February 2013 Pages: 7 - 7

28. Etoposide

    Incidence study 08 February 2013 Pages: 7 - 7

29. Fluvoxamine

    Case report 08 February 2013 Pages: 7 - 7

30. Heparin

    Case report 08 February 2013 Pages: 7 - 7

31. Docetaxel

    Incidence study 08 February 2013 Pages: 8 - 8

32. Herbal medicine

    Case report 08 February 2013 Pages: 8 - 8

33. Immunoglobulin interaction

    Clinical study 08 February 2013 Pages: 8 - 8

34. Interferon alpha

    Incidence study 08 February 2013 Pages: 8 - 8

35. Interleukin 2

    Case report 08 February 2013 Pages: 8 - 8

36. Isotretinoin

    Case report 08 February 2013 Pages: 8 - 8

37. Loperamide overdose

    Incidence study 08 February 2013 Pages: 8 - 8

38. Lormetazepam

    Case report 08 February 2013 Pages: 9 - 9

39. Maprotiline overdose

    Incidence study 08 February 2013 Pages: 9 - 9

40. Methotrexate

    Case report 08 February 2013 Pages: 9 - 9

41. Methotrexate

    Case reports 08 February 2013 Pages: 9 - 9

42. Mianserin

    Case reports 08 February 2013 Pages: 9 - 9

43. Neuropsychotherapeutics

    Incidence study 08 February 2013 Pages: 9 - 9

44. Nifedipine

    Case report 08 February 2013 Pages: 10 - 10

45. Nortriptyline

    Clinical study 08 February 2013 Pages: 10 - 10

46. Omeprazole

    Case report 08 February 2013 Pages: 10 - 10

47. Prednisone

    Incidence study 08 February 2013 Pages: 10 - 10

48. Salbutamol

    Case report 08 February 2013 Pages: 10 - 10

49. Temazepam overdose

    Case report 08 February 2013 Pages: 10 - 10

50. Theophylline overdose

    Case report 08 February 2013 Pages: 11 - 11